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Abstract
Background: Isolated splenic metastases from colorectal cancer are very rare and there are only
13 cases reported in the English literature so far. Most cases are asymptomatic and the diagnosis is
usually made by imaging studies during the evaluation of rising CEA level postoperatively.
Case presentation: A 76-year-old man underwent an extended left hemicolectomy for
synchronous colon cancers located at the left flexure and the sigmoid colon. The tumors were
staged as IIIC (T3N2M0) clinically and the patient received adjuvant chemotherapy. During the first
year follow-up period, the patient remained asymptomatic with normal levels of laboratory tests
including CEA measurement. However, a gradually rising CEA level after the 14th postoperative
month necessitated further imaging studies including computed tomography of the abdomen which
revealed a mass in the spleen that was subsequently confirmed by 18FDG- PET scanning to be an
isolated metastasis. The patient underwent splenectomy 17 months after his previous cancer
surgery. Histological diagnosis confirmed a metastatic adenocarcinoma with no capsule invasion.
After an uneventful postoperative period, the patient has been symptom-free during the one-year
of follow-up with normal blood CEA levels, although he did not accept to receive any further
adjuvant therapy. To the best of our knowledge, this 14th case of isolated splenic metastasis from
colorectal carcinoma is also the first reported case of splenic metastasis demonstrated
preoperatively by 18FDG PET-CT fusion scanning which revealed its solitary nature as well.
Conclusion: Isolated splenic metastasis is a rare finding in the follow-up of colorectal cancer
patients and long-term survival can be achieved with splenectomy.
Background
Splenic metastases from colorectal carcinoma are very rare
and usually occur as a component of disseminated dis-
ease. From the first case report of isolated metastasis to the
spleen in the setting of colorectal carcinoma by Dunbar et
al. [1] in 1969, only thirteen cases are reported in the Eng-
lish literature to date [2-13]. Twelve of them were meta-
chronous metastases, whereas the remaining one
synchronous. Although the exact incidence of splenic
metastases is still unknown, Berge [14] reported the over-
all incidence of splenic involvement as 7.1% in 7165
autopsy cases with various cancers and the incidence of
Published: 06 July 2006
World Journal of Surgical Oncology 2006, 4:42 doi:10.1186/1477-7819-4-42
Received: 13 February 2006
Accepted: 06 July 2006
This article is available from: http://www.wjso.com/content/4/1/42
© 2006 Gencosmanoglu et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.World Journal of Surgical Oncology 2006, 4:42 http://www.wjso.com/content/4/1/42
Page 2 of 6
(page number not for citation purposes)
splenic metastasis from colon and rectal carcinomas as
4.4% and 1.6%, respectively. However, he did not report
any case of solitary splenic metastasis. Anatomical, histo-
logical and functional features of spleen have been specu-
lated as the reason of the rarity for solitary cancer
metastasis [15]. Most cases are reported as asymptomatic
and the diagnosis is usually made by the imaging studies
such as abdominal ultrasound (US) or computerized tom-
ography (CT) during the evaluation of a rising CEA level
in the postoperative follow-up period of colorectal cancer
patients. To the best of our knowledge, this is the first case
in which the splenic metastasis from colorectal carcinoma
was demonstrated preoperatively by 18FDG PET-CT fusion
scanning which also revealed its solitary nature.
Case presentation
A 76-year-old man suffering from fatigue, weight loss and
rectal bleeding underwent extended left hemicolectomy
with the diagnosis of synchronous colon cancer. Preoper-
ative work-up including colonoscopy and contrast-
enhanced abdominal computed tomography (CT)
showed that the tumors located at the left flexure and the
sigmoid colon and the endoscopic biopsies revealed the
diagnosis of adenocarcinoma for both of the tumors.
There was neither liver nor other remote site metastasis in
the abdomen. The chest X-ray was normal. However, CEA
level was higher (34.63 ng/mL, Reference values: 0–10 ng/
mL) in the preoperative period (Figure 1). Histopatholog-
ical examination of the specimen revealed a moderately
differentiated adenocarcinoma, 2 cm in diameter, that
invaded into but not beyond the muscularis propria (pT2)
at the left flexure with lymphatic and vascular but not
perineural invasion and another moderately differenti-
ated adenocarcinoma, 6 cm in diameter, that invaded into
the serosa (pT3) with lymphatic, vascular and perineural
invasion. Both of the tumors had similar histologic fea-
tures that were well differentiated and complex glands
composed of stratified columnar cells with eosinophilic
cytoplasms accompanied by large necrotic areas. Four of
the nine lymph nodes were positive for metastatic adeno-
carcinoma with the presence of perinodal invasion (pN2).
Therefore, the patient was classified as stage C2 according
to the modified Astler-Coller staging system and stage IIIC
(pT3N2, cT3N2M0) according to the TNM system. He
received oral chemotherapy consisting of capecitabine
(Xeloda®, Roche) 5 × 500 mg capsule for 14 days with 7-
day interval for a total of 8 courses. Blood CEA level
decreased to the 3.54 ng/mL in the early postoperative
period and remained normal up to the 14th month of fol-
low-up. A rising CEA level (Figure 1) in this asymptomatic
case necessitated further imaging studies including
abdominal ultrasound and contrast-enhanced abdominal
and thoracic CT which revealed a hyperdense solid mass
in the lower two third of the spleen, while the liver and the
paraaortic area were disease-free. Furthermore, 18FDG-
PET scanning showed an isolated hypermetabolic state in
the spleen (Figure 2A), while PET-CT fusion scanning con-
firmed this pathological FDG uptake as superimposing
with the hypodense mass in the spleen (Figure 2B). Any
other remote organ metastases were not found by both CT
and PET scanning. Following a preoperative vaccination
against Streptococcus pneumoniae, Haemophilus influenzae,
and Neisseria meningitidis as prevention strategy to avoid
overwhelming postsplenectomy infection, the patient
underwent splenectomy 17 months after his previous
colorectal cancer surgery. At laparotomy, the tumor was in
the lower two third of the spleen without any capsule
invasion macroscopically (Figure 3) and there were nei-
ther liver nor other intraabdominal organ metastases.
Also, any lymph node involvement at splenic hilus or
paraaortic site was not detected during the operation.
Therefore, lymphadenectomy at either site was not per-
formed. Histopathologic examination of the splenectomy
specimen showed that the tumor within the spleen was a
metastasis of a moderately differentiated adenocarcinoma
with 5 × 6 × 6.5 cm in dimensions and it was sharply
demarcated from the adjacent splenic parenchyma with-
out any capsule invasion (Figure 4A). The histologic fea-
tures of this metastatic tumor were very similar to the
primary synchronous colonic adenocarcinomas (Figure
4B). Because the patient had a previous colon cancer sur-
gery and no findings of any primary tumor (i.e. adenocar-
cinoma) in any other organ except metastatic splenic
tumor at laparotomy as well as on the preoperative CT
and PET scanning besides the decrease of the high blood
CEA level to within normal limits following splenectomy
and the presence of histologic similarities between the
metastatic tumor and the primaries, the present case was
accepted as a solitary metachronous splenic metastasis
from colon cancer. The postoperative period was unevent-
The course of pre- and post-operative blood CEA levels  (Reference values: 0–10 ng/mL) Figure 1
The course of pre- and post-operative blood CEA levels 
(Reference values: 0–10 ng/mL).
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18FDG- PET scanning showed an isolated hypermetabolic state in the spleen (white arrow) (A) Figure 2
18FDG- PET scanning showed an isolated hypermetabolic state in the spleen (white arrow) (A). PET-CT fusion scanning con-
firmed that this pathological FDG uptake (red arrow) superimposed with the hypodense mass in the spleen (yellow arrow) (B).World Journal of Surgical Oncology 2006, 4:42 http://www.wjso.com/content/4/1/42
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ful. The patient has been symptom-free during the one-
year of follow-up with a normal blood CEA levels,
although he did not accept to receive any further adjuvant
therapy.
Discussion
Several theories have been postulated for the reason of the
rarity of solitary splenic metastasis from colorectal cancer.
Although the incidence of micrometastases in the spleen
secondary to colorectal carcinoma is reported as 4.4% in
careful autopsy examinations [14], the rare occurrence of
clinically apparent metastasis may propose the existence
of a certain mechanism prohibiting tumor cell prolifera-
tion in the spleen. The sharp angle of the splenic artery
with the celiac axis and the rhythmic contraction by the
sinusoidal splenic architecture were speculated as limiting
factors of metastasis [9]. Spleen is the second largest organ
of the reticuloendothelial system with profuse monocytes,
immunoglobulin synthesis, and opsonin production.
Therefore, immune surveillance appears to potently
inhibit tumor cell proliferation [9]. On the other hand,
intense destruction of malignant cells in spleen may limit
the development of splenic metastasis as supported by the
experimental evidences [16]. The absence of afferent lym-
phatics to the spleen is considered to be another reason
for such low incidence of splenic metastasis [12].
Another considerable point is the potential relationship
between the primary tumor site and isolated splenic
metastasis. In fact, in 12 of the 14 reported patients
including the present case, the primary tumor was in the
left colon (5 in sigmoid colon, 3 in descending colon, 2 in
rectum, and 2 at left flexure), whereas it was in cecum and
ascending colon in the remaining two. As previously
stated by Avesani et al. [11], this observation may support
the theory by Indudhara et al. [6]; a possible retrograde
spread to the spleen via the inferior mesenteric vein. How-
ever, this explanation has to stay theoretical; because,
there is unfortunately no current imaging study to be able
to show this type spread in an individual basis.
Diagnosis of splenic metastasis as well as other remote
organ metastasis from colorectal cancer can be made by
help of many current imaging studies such as US, CT or
MRI. However, FDG-PET scanning provides a better detec-
tion of metastatic deposits, especially when they are too
small to be shown by other radiological studies in the set-
ting of postoperatively rising CEA level. In addition, PET-
CT fusion may specifically suggest that the mass seen by
the CT is tumoral in nature. On the other hand, solitary
status of metastasis can be demonstrated and predicted
preoperatively by PET-CT fusion scanning as in the
present case. Therefore, the indication of splenectomy can
The macroscopic view of the splenectomy specimen (A) and its cross section (B) Figure 3
The macroscopic view of the splenectomy specimen (A) and its cross section (B). Note that the splenic capsule was not 
invaded by the metastatic tumor (arrows).World Journal of Surgical Oncology 2006, 4:42 http://www.wjso.com/content/4/1/42
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be justified in such cases since the presence of multiple
remote site metastases usually exterminates the chance of
surgical intervention.
Long-term survival rate following splenectomy in patients
with solitary splenic metastasis from colorectal cancer is
still unknown. However, the limited data extracted from
the case reports in the literature indicate that these
patients may survive up to 7 years [8,12,13]. The present
case is disease-free during the one-year of follow up.
Conclusion
Isolated splenic metastasis is a rare finding in the follow-
up of colorectal cancer patients and long-term survival can
be achieved with splenectomy.
Abbreviations
CEA: carcinoembryonic antigen
18FDG-PET:  18Fluorodeoxyglucose – positron emission
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Histological section of the splenic tumor showing glandular pattern consistent with metastasis from colonic adenocarcinoma  (arrows show the tumor within the splenic parenchyma), X100, Hematoxylin +Eosin (A) Figure 4
Histological section of the splenic tumor showing glandular pattern consistent with metastasis from colonic adenocarcinoma 
(arrows show the tumor within the splenic parenchyma), X100, Hematoxylin +Eosin (A). Histologic section of the primary 
colonic tumor located at the sigmoid colon with glandular pattern, X100, Hematoxylin +Eosin (B).Publish with BioMed Central    and   every 
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